Drug treatment for multidrug-resistant Acinetobacter baumannii infections

被引：79

作者：

Bassetti, Matteo ^{[1
]}

Righi, Elda ^{[2
,3
]}

Esposito, Silvano ^{[4
]}

Petrosillo, Nicola ^{[5
]}

Nicolini, Laura ^{[2
,3
]}

机构：

[1] Univ San Martino, Azienda Osped, Clin Malattie Infett, I-16132 Genoa, Italy

[2] San Martino Hosp, Div Infect Dis, Genoa, Italy

[3] Univ Genoa, Sch Med, Genoa, Italy

[4] Univ Naples 2, Dept Infect Dis, Naples, Italy

[5] Natl Inst Infect Dis L Spallanzani, Rome, Italy

来源：

FUTURE MICROBIOLOGY | 2008年 / 3卷 / 06期

关键词：

Acinetobacter baumannii; antibiotic; colistin; imipenem; meropenem; resistance; rifampin; sulbactam; therapy; tigecycline;

D O I：

10.2217/17460913.3.6.649

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Acinetobacter boumannii has emerged in the last decades as a major cause of healthcare-associated Infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. boumannii Is a rapidly emerging pathogen in healthcare settings, where it causes infections that include bacteremia, pneumonia, meningitis, and urinary tract and wound Infections. Antimicrobial resistance poses great limits for therapeutic options in infected patients, especially if the isolates are resistant to the carbapenems. Other therapeutic options include sulbactam, aminoglycosides, polymixyns and tigecycline. The discovery of new therapies coupled with the development of controlled clinical trial antibiotic testing combinations and the prevention of transmission of MDR Acinetobacter infection are essential to face this important hospital problem,

引用

页码：649 / 660

页数：12

共 137 条

[21]

Centers for Disease Control and Prevention (CDC), 2004, MMWR MORB MORTAL WKL, V53, P1063

[22]

Chang Po-Yang, 2007, Journal of Microbiology Immunology and Infection, V40, P406

[23] Prevalence of Acinetobacter baumannii carriage in patients of 53 French intensive care units on a given day [J].

Chatellier, D. ;

Burucoa, C. ;

Pinsard, M. ;

Frat, J. -P. ;

Robert, R. .

MEDECINE ET MALADIES INFECTIEUSES, 2007, 37 (02) :112-117

[24] Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3 [J].

Chau, SL ;

Chu, YW ;

Houang, ETS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :4054-4055

[25] Five-year review of infections in a burn intensive care unit:: High incidence of Acinetobacter baumannii in a tropical climate [J].

Chim, Harvey ;

Tan, Ban Hock ;

Song, Colin .

BURNS, 2007, 33 (08) :1008-1014

[26] Occurrence of carbapenern-resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England [J].

Coelho, Juliana M. ;

Turton, Jane F. ;

Kaufmann, Mary E. ;

Glover, Judith ;

Woodford, Neil ;

Warner, Marina ;

Palepou, Marie-France ;

Pike, Rachel ;

Pitt, Tyrone L. ;

Patel, Bharat C. ;

Livermore, David M. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (10) :3623-3627

[27] Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii [J].

Corbella, X ;

Ariza, J ;

Ardanuy, C ;

Vuelta, M ;

Tubau, F ;

Sora, M ;

Pujol, M ;

Gudiol, F .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :793-802

[28] Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii [J].

Corbella, X ;

Pujol, M ;

Ayats, J ;

Sendra, M ;

Ardanuy, C ;

Dominguez, MA ;

Linares, J ;

Ariza, J ;

Gudiol, F .

CLINICAL INFECTIOUS DISEASES, 1996, 23 (02) :329-334

[29] Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].

Corbella, X ;

Montero, A ;

Pujol, M ;

Domínguez, MA ;

Ayats, J ;

Argerich, MJ ;

Garrigosa, F ;

Ariza, J ;

Gudiol, F .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4086-4095

[30] AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii [J].

Damier-Piolle, Laurence ;

Magnet, Sophie ;

Bremont, Sylvie ;

Lambert, Thierry ;

Courvalin, Patrice .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :557-562

← 1 2 3 4 5 6 7 8 9 10 →